Global Hand, Foot, and Mouth Disease Treatment Market: By Virus Type (Coxsackievirus A16, Coxsackievirus A6, Enterovirus 71 (EV-A71)), Drug Type (Pain Relievers, Non-steroidal Anti-inflammatory Drugs, Nucleoside Analogue Antivirals); Route of Administration (Topical, Oral, and Intravenous); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); Region—Market Size, Industry Dynamics, Opportunity Analysis and Forecast for 2024–2032
The Global Hand, Foot, and Mouth Disease Treatment Market was valued at US$ 3,037.3 million in 2023 and is projected to generate a revenue of US$ 5,175.1 million by 2032 at a CAGR of 6.1% during the forecast period 2024–2032. Read More
We Are Trusted By These Great Companies!
Published On: 04-Apr-2024 | Format: | Report ID: AA0923609